Search results for " biopharmaceuticals"
Article
Automating the Biomanufacturing Process
As automation in biomanufacturing becomes more important, so does the need to integrate process data.
By Feliza Mirasol
unlimit3d/Stock.Adobe.com
Biomanufacturing proc…
Article
A Plastic Pipeline for Commercial Bioprocessing?
A Plastic Pipeline for Commercial Bioprocessing?
The maturation of single-use technologies presents commercial bioprocessing options for small-volume drug products.
By Rita C. Peters
…
Article
Automation Trend in Fill/Finish Reduces Contamination Risk
…isolator units and automation, potent compound handling, and more accurate filling for highly-potent biopharmaceuticals.
References
1. BioRealty, “Overview of Aseptic Fill/Finish Manufacturing,…
Article
3rd BioProcessing Asia Preview: Q&A with John Curling
…ked a forum for a science and technology-focused discussion on best practices for the development of biopharmaceuticals. We founded BioProcessing Asia to enable scientists from academia and industry,…
Article
Managing Residual Impurities During Downstream Processing
Increased understanding of potential impurities and their consequence to the ultimate quality, safety, and efficacy of biopharmaceuticals--as well as improvements in analytical technology that provide…
Article
Automating Bioprocesses
Requirements are emerging, particularly for biopharmaceuticals, to provide CPV across all manufacturing locations for a product both internally and externally (e.g., at a CMO).
Article
Biopharma in 2016: Higher Quality Drugs, Less Expensive Manufacturing
The global biopharmaceuticals market was valued at $162 billion in 2014 and pre¬dicted by Persistence Market Research to grow at a compound annual growth rate of 9.4% from 2014 to 2020 to reach $278 b…
Article
Perfusion in the 21st Century
Quality, flexibility, and cost savings are driving use of perfusion technology in biosimilars manufacturing.
By Bruce Lehr, Delia Lyons
Cell-culture technology for biopharmaceutical manufact…
Article
Managing Biomanufacturing Capacity Expectations
Capacity for complex therapeutics is becoming increasingly difficult to predict.
By Randi Hernandez
Demand for any given new product is typically only known after significant investments h…
Article
Going Small to Achieve Success on the Commercial Scale
Scale-down modeling is instrumental in supporting the development of downstream biopharma manufacturing processes.
By Cynthia A. Challener
Biopharmaceutical manufacturing involves a series o…